Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)

Dartmouth-Hitchcock Medical Center · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
breastcancer
breast cancer, er positive breast cancer, letrozole, aromatase inhibitor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 995150
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.